These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 36176536)

  • 21. Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants.
    Carlsen EØ; Magnus MC; Oakley L; Fell DB; Greve-Isdahl M; Kinge JM; Håberg SE
    JAMA Intern Med; 2022 Aug; 182(8):825-831. PubMed ID: 35648413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severity of the Omicron SARS-CoV-2 variant compared with the previous lineages: A systematic review.
    Arabi M; Al-Najjar Y; Mhaimeed N; Salameh MA; Paul P; AlAnni J; Abdelati AA; Laswi I; Khanjar B; Al-Ali D; Elshafeey A; Mhaimeed O; Burney Z; D'Souza A; Sinha P; Bhatti M; Pillai KV; Homssi M; Bshesh K; Yagan L; Zakaria D
    J Cell Mol Med; 2023 Jun; 27(11):1443-1464. PubMed ID: 37203288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a light at the end of the tunnel?
    Mattiuzzi C; Henry BM; Lippi G
    Int J Infect Dis; 2022 May; 118():167-168. PubMed ID: 35278677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamics of hospitalizations and in-hospital deaths from COVID-19 in northeast Brazil: a retrospective analysis based on the circulation of SARS-CoV-2 variants and vaccination coverage.
    Martins-Filho PR; de Souza Araújo AA; Quintans-Júnior LJ; Soares BDS; Barboza WS; Cavalcante TF; Santos VS
    Epidemiol Health; 2022; 44():e2022036. PubMed ID: 35413166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
    Fleming-Dutra KE; Britton A; Shang N; Derado G; Link-Gelles R; Accorsi EK; Smith ZR; Miller J; Verani JR; Schrag SJ
    JAMA; 2022 Jun; 327(22):2210-2219. PubMed ID: 35560036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
    Ferdinands JM; Rao S; Dixon BE; Mitchell PK; DeSilva MB; Irving SA; Lewis N; Natarajan K; Stenehjem E; Grannis SJ; Han J; McEvoy C; Ong TC; Naleway AL; Reese SE; Embi PJ; Dascomb K; Klein NP; Griggs EP; Konatham D; Kharbanda AB; Yang DH; Fadel WF; Grisel N; Goddard K; Patel P; Liao IC; Birch R; Valvi NR; Reynolds S; Arndorfer J; Zerbo O; Dickerson M; Murthy K; Williams J; Bozio CH; Blanton L; Verani JR; Schrag SJ; Dalton AF; Wondimu MH; Link-Gelles R; Azziz-Baumgartner E; Barron MA; Gaglani M; Thompson MG; Fireman B
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):255-263. PubMed ID: 35176007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness of vaccination on the COVID-19 epidemic in California.
    Huang E; Kurkure S; Seo Y; Lau K; Puglisi J
    Am J Infect Control; 2024 Nov; 52(11):1252-1257. PubMed ID: 38825240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing Epidemiology of COVID-19 in Children and Adolescents Over Four Successive Epidemic Waves in South Africa, 2020-2022.
    Chiwandire N; Jassat W; Groome M; Kufa T; Walaza S; Wolter N; von Gottberg A; Zar HJ; Reubenson G; Tempia S; Ebonwu J; Govender N; Ntshoe G; Shonhiwa AM; Blumberg L; Cohen C
    J Pediatric Infect Dis Soc; 2023 Apr; 12(3):128-134. PubMed ID: 36648247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: A world-wide review.
    Wang C; Liu B; Zhang S; Huang N; Zhao T; Lu QB; Cui F
    J Med Virol; 2023 Jan; 95(1):e28118. PubMed ID: 36056540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-year follow-up of the COVID-19 pandemic in Mexico.
    Loza A; Wong-Chew RM; Jiménez-Corona ME; Zárate S; López S; Ciria R; Palomares D; García-López R; Iša P; Taboada B; Rosales M; Boukadida C; Herrera-Estrella A; Mojica NS; Rivera-Gutierrez X; Muñoz-Medina JE; Salas-Lais AG; Sanchez-Flores A; Vazquez-Perez JA; Arias CF; Gutiérrez-Ríos RM
    Front Public Health; 2022; 10():1050673. PubMed ID: 36711379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants.
    Chen Y; Chen L; Yin S; Tao Y; Zhu L; Tong X; Mao M; Li M; Wan Y; Ni J; Ji X; Dong X; Li J; Huang R; Shen Y; Shen H; Bao C; Wu C
    Emerg Microbes Infect; 2022 Dec; 11(1):1524-1536. PubMed ID: 35608053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa.
    Davies MA; Kassanjee R; Rousseau P; Morden E; Johnson L; Solomon W; Hsiao NY; Hussey H; Meintjes G; Paleker M; Jacobs T; Raubenheimer P; Heekes A; Dane P; Bam JL; Smith M; Preiser W; Pienaar D; Mendelson M; Naude J; Schrueder N; Mnguni A; Le Roux S; Murie K; Prozesky H; Mahomed H; Rossouw L; Wasserman S; Maughan D; Boloko L; Smith B; Taljaard J; Symons G; Ntusi NAB; Parker A; Wolter N; Jassat W; Cohen C; Lessells R; Wilkinson RJ; Arendse J; Kariem S; Moodley M; Wolmarans M; Cloete K; Boulle A;
    Trop Med Int Health; 2022 Jun; 27(6):564-573. PubMed ID: 35411997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paediatric admissions with SARS-CoV-2 during the Delta and Omicron waves: an Australian single-centre retrospective study.
    Cheng DR; Schrader S; McMinn A; Crawford NW; Tosif S; Mcnab S; Steer AC
    BMJ Paediatr Open; 2023 Mar; 7(1):. PubMed ID: 36882231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
    Britton A; Embi PJ; Levy ME; Gaglani M; DeSilva MB; Dixon BE; Dascomb K; Patel P; Schrader KE; Klein NP; Ong TC; Natarajan K; Hartmann E; Kharbanda AB; Irving SA; Dickerson M; Dunne MM; Raiyani C; Grannis SJ; Stenehjem E; Zerbo O; Rao S; Han J; Sloan-Aagard C; Griggs EP; Weber ZA; Murthy K; Fadel WF; Grisel N; McEvoy C; Lewis N; Barron MA; Nanez J; Reese SE; Mamawala M; Valvi NR; Arndorfer J; Goddard K; Yang DH; Fireman B; Ball SW; Link-Gelles R; Naleway AL; Tenforde MW
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(42):1335-1342. PubMed ID: 36264840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis.
    Korves C; Izurieta HS; Smith J; Zwain GM; Powell EI; Balajee A; Ryder KM; Young-Xu Y
    Vaccine; 2022 Aug; 40(33):4742-4747. PubMed ID: 35773122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Omicron wave in Mexico: vaccine protection against progression to severe Covid-19 in SARS-CoV-2-infected workers.
    Hernández-Ávila M; Vieyra-Romero WI; Gutiérrez-Díaz HO; Zepeda-Tello R; Alpuche-Aranda C; Hernández-Ávila JE; Barros-Sierra D; Tamayo-Ortiz M; Duque-Molina C; Barrientos-Gutiérrez T; Carnalla-Cortés M; Dyer-Leal D; López-Ridaura R; López-Gatell-Ramírez H
    Salud Publica Mex; 2023 Dec; 66(1, ene-feb):85-94. PubMed ID: 38065107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics, outcome, duration of hospitalization, and cycle threshold of patients with COVID-19 referred to four hospitals in Babol City: a multicenter retrospective observational study on the fourth, fifth, and sixth waves.
    Sadeghi F; Halaji M; Shirafkan H; Pournajaf A; Ghorbani H; Babazadeh S; Ezami N; Fallhpour K; Fakhraie F; Gorjinejad S; Amoli SS; Amiri FH; Baghershiroodi M; Ahmadnia Z; Salehi M; Tourani M; Jafarzadeh J; Tabari FS; Ahmadian SR; Mohammadi Abandansari R; Jafarian F; Rouhi S; Zabihollahi A; Mostafanezhad S; Saeedi F; Ebrahimian A; Deldar Z; Zavareh MSH; Bayani M; Broun MB; Shirzad M; Sabbaghi S; Mohammadi M; Rahmani R; Yahyapour Y
    BMC Infect Dis; 2024 Jan; 24(1):55. PubMed ID: 38184533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis.
    Zeng B; Gao L; Zhou Q; Yu K; Sun F
    BMC Med; 2022 May; 20(1):200. PubMed ID: 35606843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.